| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2022―May―12 |
T HELPER CELL SUBSETS AND THEIR TARGET CELLS IN ACUTE COVID-19 |
I. Kudryavtsev, A. Golovkin, A. Totolian |
| 2 |
[GO] |
2022―May―12 |
PATHOMORPHOLOGICAL FEATURES OF ARDS IN COMPETING LUNG DISEASES: COVID-19 AND SARCOIDOSIS |
О. V. Vorobeva, N. E. Gimaldinova, L. P. Romanova |
| 3 |
[GO] |
2022―May―12 |
Comparison of the humoral and cellular immunity in COVID-19 convalescents |
Anna P. Toptygina, Elena L. Semikina, Rustam Sh. Zakirov, Zulfiia E. Afridonova |
| 4 |
[GO] |
2022―May―12 |
FEATURES OF THE NEW CORONAVIRUS INFECTION COVID-19 IN IDENTICAL TWINS |
S. Yudina, V. Kiseleva, T. Rusanova, I. Ivanova |
| 5 |
[GO] |
2022―May―12 |
RESISTANCE FACTORS OF KLEBSIELLA PNEUMONIAE BACTERIA DURING COVID-19 PANDEMIC |
O. N. Kolotova, L. V. Kataeva, I. V. Bakshtanovskaya, K. B. Stepanova, T. F. Stepanova |
| 6 |
[GO] |
2022―May―12 |
RHINO- AND RS-VIRUSES IN THE COVID-19 PANDEMIC |
I. V. Kiseleva, A. D. Ksenafontov |
| 7 |
[GO] |
2022―May―12 |
EVALUATION OF SERUM LEVELS OF IL-6 AND ADIPONECTIN IN COVID-19 PATIENTS AND THEIR RELATIONSHIP WITH DISEASE SEVERITY |
M. Norouzian, Khojasteh Sharifi-Sarasiabi, Majid Najafi-Asl, M. Hassani Azad, H. Estabraghnia Babaki |
| 8 |
[GO] |
2022―May―12 |
Local and systemic adverse reactions following COVID-19 vaccine (clinical report) |
N. Yu. Zherebtsova, T. V. Kajdanek |
| 9 |
[GO] |
2022―May―12 |
QUANTITATIVE AND QUALITATIVE COMPOSITION OF LYMPHOCYTE POPULATIONS AND SUBSETS IN PATIENTS WITH VARYING SEVERITY OF A NEW CORONAVIRUS INFECTION |
I. A. Ivanova, A. A. Trufanova, A. V. Filippenko, N. D. Omelchenko, A. K. Noskov, O. S. Chemisova |
| 10 |
[GO] |
2022―May―12 |
EVALUATION OF THE TWO IN-PATIENT HOSPITALS ON POTENTIAL ENVIRONMENTAL HAZARD DURING THE PERIOD OF NEW CORONAVIRUS INFECTION IN THE KHABAROVSK CITY (DECEMBER 2020 - MARCH 2021) |
O. E. Trotsenko, A. P. Bondarenko, N. Y. Pshenichnaya, T. A. Zaitseva, Y. A. Garbuz, I. V. Chishagorova, et al. (+3) V. A. Shmylenko, E. A. Bazykina, O. N. Ogienko |
| 11 |
[GO] |
2022―May―12 |
Anti-interferon alpha autoantibodies and their significance in COVID-19 |
S. S. Petrikov, N. V. Borovkova, K. A. Popugaev, Mayya V. Storozheva, A. M. Kvasnikov, M. A. Godkov |
| 12 |
[GO] |
2022―May―12 |
The third ethical commentary to COVID-19 (two years later) - vaccination, solidarity, and trust |
O. I. Kubar, G. L. Mikirtichan, E. Yu. Vladimirova, T. G. Taghi-zade, F. M. Mamedova, U. K. Gadgieva, et al. (+8) S. A. Davtyan, F. M. Mavsisyan, U. M. Tilekeeva, R. K. Gramma, F. Yu. Nasyrova, F. H. Tishkova, Z. M. Mukhamedova, F. S. Atamuradova |
| 13 |
[GO] |
2022―Mar―14 |
Etiological pattern of community-acquired pneumonia related to the new coronavirus infection COVID-19 pandemic in the Saratov Region |
S. A. Portenko, E. S. Kazakova, E. V. Naidenova, N. A. Osina, M. V. Proskuriakova, A. D. Katyshev, et al. (+11) E. A. Sharkova, O. V. Kedrova, E. A. Chumachkova, M. R. Shamyunov, V. F. Kharitonova, L. A. Gureva, N. Yu. Popova, L. V. Maksimova, S. A. Bugorkova, S. A. Scherbakova, V. V. Kutyrev |
| 14 |
[GO] |
2022―Mar―14 |
Revealing measles cases in Vietnam during the spread of a new coronavirus infection |
I. N. Lavrentieva, M. Hoang, A. Y. Antipova, M. A. Bichurina, A. A. Totolyan |
| 15 |
[GO] |
2022―Mar―14 |
<i>In vitro</i> antiviral activity of VIFERON® rectal suppositories against SARS-CoV-2 |
I. N. Isakova-Sivak, E. A. Stepanova, L. G. Rudenko, M. S. Bartov, E. N. Vyzhlova, V. V. Malinovskaya |
| 16 |
[GO] |
2021―Dec―15 |
Differential and diagnostic significance of monocytosis in treatment of moderate forms of COVID-19 |
M. Shperling, E. Shperling, A. Kovalev, A. Vlasov, A. Polyakov, Ya. Noskov, et al. (+4) A. Morozov, V. Merzlyakov, D. Zvyagintsev, V. Tishko |
| 17 |
[GO] |
2021―Dec―15 |
Gender-Related Response of Body Systems in COVID-19 Affects Outcome |
M. Khaksari, N. Sabet, Z. Soltani, H. Bashiri |
| 18 |
[GO] |
2021―Dec―15 |
INFLUENCE OF ULTRAVIOLET BLOOD IRRADIATION ON COVID-19 ASSOCIATED COMMUNITY-ACQUIRED PNEUMONIA |
I. Khodza, P. Puzdryak, P Bondarenko, A. Degtyarev, A. Erofeev, K. Chizhova, et al. (+2) V. Shlomin, E. Vedernikova |
| 19 |
[GO] |
2021―Dec―15 |
SALIENT FEATURES OF CIRCULATING RESPIRATORY VIRUSES IN THE PRE- AND PANDEMIC INFLUENZA AND COVID-19 SEASONS |
I. V. Kiseleva, N. V. Larionova, E. P. Grigorieva, A. D. Ksenafontov, M. Al Farroukh, L. G. Rudenko |
| 20 |
[GO] |
2021―Dec―15 |
The correlation between RAS and COVID-19, short review of the latest evidence |
F. Ferrara, A. Vitiello |
| 21 |
[GO] |
2021―Dec―15 |
IMMUNOGRAPH-BASED ANALYSIS OF THE INFLUENZA A (H1N1)PDM09 VACCINE STRAIN IMMUNOGENICITY IN THE PANDEMIC AND POST-PANDEMIC PERIOD (2009-2014) |
V. S. Vakin, I. V. Amosova, E. M. Vojcekhovskaya, T. A. Timoshicheva, A. A. Vasileva, M. G. Pozdnyakova, et al. (+4) L. V. Lyalina, V. A. Marchenko, I. Yu. Nikonorov, M. P. Grudinin |
| 22 |
[GO] |
2021―Nov―22 |
Study of features of humoral immune response to the new coronavirus infection COVID-19 among healthcare workers |
I. D. Reshetnikova, Yu. A. Tyurin, E. V. Agafonova, S. N. Kulikov, G. F. Gilyazutdinova, D. V. Lopushov, et al. (+3) N. D. Shaуkhrazieva, G. Sh. Isaeva, V. B. Ziatdinov |
| 23 |
[GO] |
2021―Nov―22 |
Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic |
A. Yu. Popova, A. A. Tarasenko, V. Yu. Smolensky, S. A. Egorova, V. S. Smirnov, A. M. Dashkevich, et al. (+37) T. N. Svetogor, I. N. Glinskaya, A. L. Skuranovich, A. M. Milichkina, A. M. Dronina, E. O. Samoilovich, I. V. Khamitova, G. V. Semeiko, T. V. Amvrosyeva, N. P. Shmeleva, L. V. Rubanik, O. P. Esmanchik, I. A. Karaban, V. G. Drobyshevskaya, G. V. Sadovnikova, M. V. Shilovich, E. A. Podushkina, V. V. Kireichuk, O. A. Petrova, S. V. Bondarenko, I. F. Salazhkova, L. M. Tkach, L. P. Shepelevich, N. L. Autukhova, V. M. Ivanov, A. S. Babilo, M. V. Navyshnaya, N. N. Belyaev, E. V. Zueva, L. A. Volosar, V. N. Verbov, I. V. Likhachev, T. O. Zagorskaya, N. F. Morozova, Z. R. Korobova, A. V. Gubanova, A. A. Totolian |
| 24 |
[GO] |
2021―Sep―21 |
COVID-19 as a zoonotic infection |
A. N. Kulichenko, O. V. Maletskaya, N. S. Sarkisyan, A. S. Volynkina |
| 25 |
[GO] |
2021―Sep―21 |
Methodology for assessing herd immunity to the SARS-CoV-2 virus in the context of the COVID-19 pandemic |
A. Yu. Popova, A. A. Totolian |
| 26 |
[GO] |
2021―Mar―24 |
Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation |
A. Yu. Popova, E. E. Andreeva, E. A. Babura, S. V. Balakhonov, N. S. Bashketova, M. V. Bulanov, et al. (+27) N. N. Valeullina, D. V. Goryaev, N. N. Detkovskaya, E. B. Ezhlova, N. N. Zaitseva, O. A. Istorik, I. V. Kovalchuk, D. N. Kozlovskikh, S. V. Kombarova, O. P. Kurganova, V. V. Kutyrev, A. E. Lomovtsev, L. A. Lukicheva, L. V. Lyalina, A. A. Melnikova, O. M. Mikailova, A. K. Noskov, L. N. Noskova, E. E. Oglezneva, T. P. Osmolovskay, M. A. Patyashina, N. A. Penkovskaya, L. V. Samoilova, V. S. Smirnov, T. F. Stepanova, O. E. Trotsenko, Areg A. Totolyan |
| 27 |
[GO] |
2021―Mar―24 |
A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18-60 years (phase I-II) |
A. B. Ryzhikov, Е. А. Ryzhikov, M. P. Bogryantseva, S. V. Usova, E. D. Danilenko, E. A. Nechaeva, et al. (+17) O. V. Pyankov, O. G. Pyankova, A. S. Gudymo, S. A. Bodnev, G. S. Onkhonova, E. S. Sleptsova, V. I. Kuzubov, N. N. Ryndyuk, Z. I. Ginko, V. N. Petrov, A. A. Moiseeva, P. Yu. Torzhkova, S. A. Pyankov, T. V. Tregubchak, D. V. Antonec, E. V. Gavrilova, R. A. Maksyutov |
| 28 |
[GO] |
2021―Mar―02 |
Second ethical comments towards COVID-19 (one year later) |
O. I. Kubar, M. A. Bichurina, N. I. Romanenkova |
| 29 |
[GO] |
2020―Sep―28 |
Parthenolide: suggested drug for COVID-19 |
M. Nemati, F. Danesh Pouya, E. Roshani Asl, Y. Rami |
| 30 |
[GO] |
2020―Sep―28 |
THE COVID-19 PANDEMIC: A SYSTEMATIC REVIEW OF THE CURRENT EVIDENCE |
R. Ghomi, N. Asgari, A. Hajiheydari, R. Esteki, F. Biyabanaki, F. Nasirinasab |
| 31 |
[GO] |
2020―Aug―08 |
Organ-specific pathomorphological changes during COVID-19 |
O. V. Vorobeva, A. V. Lastochkin |
| 32 |
[GO] |
2020―Aug―08 |
COVID-19 and BCG vaccine: is there a link? |
I. V. Lyadova, A. A. Starikov |
| 33 |
[GO] |
2020―Aug―08 |
Lessons to learn: COVID-19 epidemic in Italy |
A. V. Semenov, N. Y. Pshenichnaya |
| 34 |
[GO] |
2020―Aug―08 |
COVID-19: etiology, clinical picture, treatment |
M. Yu. Shchelkanov, L. V. Kolobukhina, O. A. Burgasova, I. S. Kruzhkova, V. V. Maleev |
| 35 |
[GO] |
2020―Aug―08 |
Some opportunities for immunotherapy in coronavirus infection |
V. S. Smirnov, Areg A. Totolian |
| 36 |
[GO] |
2020―May―22 |
An early assessment of the efficacy of medicines in the treatment of patients with COVID-19 |
A. S. Kolbin |
| 37 |
[GO] |
2020―May―22 |
COVID-19: an updated review |
F. A. Isihak, M. A. Hamad, N. G. Mustafa |
| 38 |
[GO] |
2020―Apr―12 |
INNATE IMMUNITY IN CORONAVIRUS INFECTION |
V. Smirnov, A. Totolyan |
| 39 |
[GO] |
2020―Apr―12 |
THE HISTORY OF INVESTIGATION AND MODERN CLASSIFICATION OF CORONAVIRUSES (NIDOVIRALES: CORONAVIRIDAE) |
M. Yu. Shchelkanov, A. Yu. Popova, V. G. Dedkov, V. G. Akimkin, V. V. Maleyev |
|
